COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia.
Helvécio Cardoso Corrêa PóvoaGabriela Ceccon ChiancaNatalia Lopes Pontes Póvoa IorioPublished in: Infectious diseases and therapy (2020)
This manuscript aims to highlight the risk of Ventilator-Associated Bacterial Pneumonia (VAP) in COVID-19 inpatients. The co-infection has the potential to worsen clinical condition and increase mortality in these patients, as well as to prolong and increase the costs of hospitalization. Preventing, identifying and treating early VAP can increase the chances of successful treatment in patients with COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- type diabetes
- cardiovascular events
- cardiovascular disease
- coronary artery disease
- patient reported outcomes
- climate change
- intensive care unit
- respiratory failure
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- community acquired pneumonia